Companies: 10,795·Total market cap: $144.5T
IRIDEX Corporation

IRIDEX Corporation

IRIXNASDAQHealthcare● Active
$1.11
+$0.02(+1.83%)
Market Cap$19321215
P/E Ratio
52W High$1.65
52W Low$0.87
Overview

IRIDEX Corporation(IRIX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

irix · 股价预测 · 4 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 4 位华尔街分析师

SellBuy

Buy

4 位分析师

共识

评级分布

Strong Buy
0
Buy
3
Hold
1
Sell
0
Strong Sell
0
合计: 4 · 买入占比: 75.0%

12 个月目标价

High

$2.75

Consensus

$2.75

+147.7% upside

Low

$2.75

Median: $2.75 · Last Close: $1.11

IRIDEX Corporation(IRIX)的分析师共识为 Buy,基于过去 3 个月内 4 位华尔街分析师的评级。IRIX 的 12 个月平均目标价为 $2.75,相对当前价 $1.11 代表 +147.7% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$1.164.91%

1-day model range: $1.16–$1.17. Peak: $1.17 (+4.91%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$1-23.4%
2028$1-32.3%
2029$1-36.3%
2030$1-38.1%
2031-39.0%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%7%43%
7Buy
1Neutral
6Sell
RSI (14)63.2Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · IRIX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$1.13SELL
MA 10$1.09BUY
MA 20$1.06BUY
MA 50$1.04BUY
MA 100$1.22SELL
MA 200$1.17SELL
Current $IRIX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1.11SELL
EMA 10$1.10BUY
EMA 20$1.08BUY
EMA 50$1.09BUY
EMA 100$1.14SELL
EMA 200$1.18SELL
Current $IRIX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Stifel2024-05-15
Maintains
HoldHold
Stifel2022-08-26
Downgrade ↓
BuyHold
Roth Capital2021-05-12
Maintains
BuyBuy
Roth Capital2021-03-03
Maintains
BuyBuy
Roth Capital2021-01-13
Maintains
BuyBuy
Stifel2020-05-12
Maintains
BuyBuy
Stifel2019-01-04
Maintains
BuyBuy
Stifel Nicolaus2019-01-04
Maintains
BuyBuy
Stifel Nicolaus2018-10-26
Maintains
BuyBuy
Roth Capital2016-12-21
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on IRIDEX Corporation (IRIX) stock. Of the recent 11 rating actions, 0 were upgrades and 1 were downgrades. 4 analysts currently cover IRIX.

分析师推荐趋势

Buy ratings101
Hold ratings01↑ +1
Sell ratings00

IRIX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$50M

↓ 6.4% YoY

Revenue Next Year

$53M

↑ 6.2% YoY

EPS This Year

$-0.52

EPS Next Year

$-0.27

↓ 48.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast IRIX EPS of $-0.52 for the current fiscal year, based on estimates from 1 analysts. The IRIX revenue forecast is $50M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

IRIX 股价预测由两类独立数据源支撑:来自 4 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。IRIX 的共识目标价为 $2.75(+147.7% 上行空间),分析师共识为 Buy。

IRIX 的短期预测(明日)为 $1.16(+4.91%)。 IRIX 对 2027 年的股价预测均值为 $1。 IRIX 对 2030 年的预测区间为 $1–$1。

IRIDEX Corporation 在 NASDAQ 上市,代码 IRIX。IRIX 在 2027 年的整体展望偏积极,在覆盖分析师中约 75% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

IRIX 预测 · 8 个问题

根据 4 位华尔街分析师,IRIX 的 12 个月平均目标价为 $2.75,最高 $2.75、最低 $2.75。若有图表,中位目标价可在上方查看。相对当前价 $1.11,隐含约 +147.7% 的上行空间。

IRIX 目标价IRIX 分析师目标价IRIX 12个月目标价目标价 IRIX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.